KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Non-cash Items (2016 - 2017)

Historic Non-cash Items for Biomarin Pharmaceutical (BMRN) over the last 8 years, with Q4 2017 value amounting to $281.1 million.

  • Biomarin Pharmaceutical's Non-cash Items fell 762.76% to $281.1 million in Q4 2017 from the same period last year, while for Dec 2017 it was $281.1 million, marking a year-over-year decrease of 762.76%. This contributed to the annual value of $281.1 million for FY2017, which is 762.76% down from last year.
  • Latest data reveals that Biomarin Pharmaceutical reported Non-cash Items of $281.1 million as of Q4 2017, which was down 762.76% from $304.4 million recorded in Q4 2016.
  • In the past 5 years, Biomarin Pharmaceutical's Non-cash Items registered a high of $630.9 million during Q4 2015, and its lowest value of $281.1 million during Q4 2017.
  • Its 5-year average for Non-cash Items is $458.8 million, with a median of $477.6 million in 2013.
  • In the last 5 years, Biomarin Pharmaceutical's Non-cash Items skyrocketed by 537575.29% in 2013 and then tumbled by 5176.22% in 2016.
  • Over the past 5 years, Biomarin Pharmaceutical's Non-cash Items (Quarter) stood at $477.6 million in 2013, then rose by 25.65% to $600.1 million in 2014, then grew by 5.14% to $630.9 million in 2015, then crashed by 51.76% to $304.4 million in 2016, then dropped by 7.63% to $281.1 million in 2017.
  • Its Non-cash Items was $281.1 million in Q4 2017, compared to $304.4 million in Q4 2016 and $630.9 million in Q4 2015.